PGY-2 Oncology
Program Overview & Goals
The UC Irvine Health PGY2 Oncology Residency programs build upon Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency training to develop pharmacist practitioners with knowledge, skill, and abilities as defined in the educational competency areas, goals, and objectives for advanced practice areas. Residents who successfully complete PGY2 residency programs are prepared for advanced patient care or other specialized positions, and board certification in the advance practice area, if available.
The UC Irvine Chao Family Comprehensive Cancer Center (UCI CFCCC) was established in 1989 as a university-based cancer center, National Cancer Institute (NCI) designated in 1994, and comprehensive cancer center status in 1997. UCI CFCCC is the only NCI-designated and comprehensive cancer center based in Orange County with a mission to develop new knowledge about the etiology, causes, prevention, diagnosis, and treatment of cancers. UCI CFCCC continues to expand treatment options with one of the largest early phase clinical trials programs in Southern California and proudly offers growing treatment options in our FACT accredited stem cell transplant and cellular therapy program. Our multidisciplinary team consists of world-class oncologists, surgeons, radiation oncologists, pathologists, nurses, rehabilitation therapists, pharmacists, social workers and dietitians works together seamlessly to treat cancers of all types and degrees of severity.
- Orientation
- Infusion Center
- Inpatient Hematology/Oncology I (IP Heme/Onc I)
- Inpatient Hematology/Oncology II (IP Heme/Onc II)
- Inpatient Hematopoietic Stem Cell Transplant and Cellular Therapy (IP HSCTCT)
- Ambulatory Hematopoietic Stem Cell Transplant and Cellular Therapy (HSCTCT)
- Investigational Drug Services (IDS)
- Ambulatory Oncology Lung/Genitourinary (GU)
- Ambulatory Oncology Gastrointestinal (GI) and Melanoma/Sarcoma
- Ambulatory Oncology Breast and Head/Neck
- Oncology Forum Presentations
- Continuing Education (CE) Presentation
- Residency Research Project
- Pharmacy Administration (P&T/Drug Monograph, Medication Use Evaluation, and Medication Safety)
- Community Service Project
- Inpatient and Outpatient Oncology Staffing (every 3rd weekend including a major and minor holiday)
Resident may select up to 2 electives, repeat a core rotation, or work with the RPD to develop a new elective learning experience.
Available Electives
- Immunocompromised Infectious Diseases
- Pain and Palliative Care
- Medical ICU
- Academia
Application Information
Requirements to Apply:
- Applicants must have graduated from an accredited school of pharmacy with a Doctor of Pharmacy degree and in process of completing or have completed an ASHP-accredited or candidate-status PGY1 residency.
- Applicant must be registered for the ASHP Resident Matching Program (the “Match”)
- Eligible for California Pharmacist Licensing Exam immediately after PGY2 program commitment. A valid license must be obtained by November 1st of residency year.
- Application through the PHORCAS system
- Letter of intent
- Curriculum vitae
- Three professional references
- Academic transcripts
Interview and Selection Process Information:
- All eligible applicants’ packets submitted in PhORCAS will be screened. The offer to interview will include relevant policies, salaries, benefits, and requirements for successful completion of the program.
Benefits:
- $81,432 stipend as of 2024-2025 year
- Allowed 2 weeks paid vacation
- Travel expenses and time off to attend approved pharmacy conference (Stipend amount varies and to be determined per meeting budget)
- Medical, Dental, and Vision insurance through UCI Health sponsored plan
Application Deadline: Early January
Number of Positions Available: 1
Program Code: 01107 (ASHP Candidate Status)
Program Contacts
Jean Doh PharmD, BCOP
PGY2 Oncology Residency Program Director
Division of Pharmacy
Chao Family Comprehensive Cancer Center
University of California, UC Irvine Health
101 The City Drive South, Orange, CA 92868
dohjy@hs.uci.edu
Current PGY-2 Oncology Resident
Jenny Liu, Pharm.D.
Pharmacy School: Western University of Health Sciences
Practice/Research interests: Hematology/Oncology, Hematopoietic Stem Cell Transplant
Current Research Project: A real-world, multicenter dataset of treatment outcomes and adverse events for patients with multiple myeloma